GERN
Price
$3.77
Change
-$0.15 (-3.82%)
Updated
Dec 18, 04:59 PM (EDT)
78 days until earnings call
LIANY
Price
$0.27
Change
+$0.02 (+8.00%)
Updated
Dec 17 closing price
96 days until earnings call
Ad is loading...

GERN vs LIANY

Header iconGERN vs LIANY Comparison
Open Charts GERN vs LIANYBanner chart's image
Geron
Price$3.77
Change-$0.15 (-3.82%)
Volume$246.31K
CapitalizationN/A
LianBio
Price$0.27
Change+$0.02 (+8.00%)
Volume$247.3K
CapitalizationN/A
GERN vs LIANY Comparison Chart
Loading...
GERN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LIANY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GERN vs. LIANY commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GERN is a Buy and LIANY is a Sell.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (GERN: $3.93 vs. LIANY: $0.27)
Brand notoriety: GERN and LIANY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GERN: 97% vs. LIANY: 313%
Market capitalization -- GERN: $2.38B vs. LIANY: $28.72M
GERN [@Biotechnology] is valued at $2.38B. LIANY’s [@Biotechnology] market capitalization is $28.72M. The market cap for tickers in the [@Biotechnology] industry ranges from $482.1B to $0. The average market capitalization across the [@Biotechnology] industry is $2.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GERN’s FA Score shows that 1 FA rating(s) are green whileLIANY’s FA Score has 1 green FA rating(s).

  • GERN’s FA Score: 1 green, 4 red.
  • LIANY’s FA Score: 1 green, 4 red.
According to our system of comparison, both GERN and LIANY are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GERN’s TA Score shows that 4 TA indicator(s) are bullish while LIANY’s TA Score has 4 bullish TA indicator(s).

  • GERN’s TA Score: 4 bullish, 3 bearish.
  • LIANY’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, GERN is a better buy in the short-term than LIANY.

Price Growth

GERN (@Biotechnology) experienced а -1.50% price change this week, while LIANY (@Biotechnology) price change was -2.46% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.67%. For the same industry, the average monthly price growth was -1.92%, and the average quarterly price growth was +0.65%.

Reported Earning Dates

GERN is expected to report earnings on Mar 06, 2025.

LIANY is expected to report earnings on Mar 24, 2025.

Industries' Descriptions

@Biotechnology (-6.67% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GERN($2.38B) has a higher market cap than LIANY($28.7M). GERN YTD gains are higher at: 86.256 vs. LIANY (56.169).
GERNLIANYGERN / LIANY
Capitalization2.38B28.7M8,279%
EBITDA-187.93MN/A-
Gain YTD86.25656.169154%
P/E RatioN/AN/A-
Revenue29.5MN/A-
Total Cash340MN/A-
Total Debt87.3MN/A-
FUNDAMENTALS RATINGS
GERN: Fundamental Ratings
GERN
OUTLOOK RATING
1..100
69
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
PROFIT vs RISK RATING
1..100
23
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
51
P/E GROWTH RATING
1..100
80
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GERNLIANY
RSI
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
78%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
77%
Momentum
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
82%
MACD
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 9 days ago
76%
Bullish Trend 17 days ago
83%
Declines
ODDS (%)
Bearish Trend 3 days ago
76%
Bearish Trend 3 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 2 days ago
87%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Ad is loading...
GERN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LIANY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FARCX15.61-0.06
-0.38%
Nuveen Real Estate Securities I
FRESX41.13-0.19
-0.46%
Fidelity Real Estate Investment Port
VFWPX124.28-0.61
-0.49%
Vanguard FTSE All-Wld ex-US Idx Ins Plus
MOWNX16.36-0.14
-0.85%
Moerus Worldwide Value N
PPQMX10.90-0.10
-0.91%
Principal MidCap Growth III R3

GERN and

Correlation & Price change

A.I.dvisor indicates that over the last year, GERN has been closely correlated with SER. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if GERN jumps, then SER could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GERN
1D Price
Change %
GERN100%
+3.15%
SER - GERN
67%
Closely correlated
+15.42%
LIANY - GERN
53%
Loosely correlated
+4.24%
VCYT - GERN
44%
Loosely correlated
-2.52%
MIRM - GERN
39%
Loosely correlated
+0.61%
NRIX - GERN
37%
Loosely correlated
+1.78%
More

LIANY and

Correlation & Price change

A.I.dvisor indicates that over the last year, LIANY has been closely correlated with SER. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if LIANY jumps, then SER could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LIANY
1D Price
Change %
LIANY100%
+4.24%
SER - LIANY
69%
Closely correlated
+15.42%
GERN - LIANY
53%
Loosely correlated
+3.15%
TRML - LIANY
28%
Poorly correlated
-1.09%
OTLK - LIANY
23%
Poorly correlated
+0.70%
MTNB - LIANY
21%
Poorly correlated
+10.16%
More